Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0CT9C
|
||||
| Former ID |
DAP000532
|
||||
| Drug Name |
Cyclophosphamide
|
||||
| Synonyms |
ASTA; Ciclofosfamida; Ciclophosphamide; Clafen; Claphene; Cycloblastin; Cyclophosphamid; Cyclophosphamides; Cyclophosphamidum; Cyclophosphan; Cyclophosphane; Cyclophosphanum; Cyclophosphoramide; Cyclostin; Cyklofosfamid; Cytophosphan; Cytophosphane; Cytoxan; Endoxan; Endoxana; Endoxanal; Endoxane; Enduxan; Genoxal; Mitoxan; Neosar; Procytox; Revimmune; Semdoxan; Sendoxan; Senduxan; Zyklophosphamid; Ciclophosphamide [INN]; Cyclophosphamide Sterile; Cyclophosphamide anhydrous; Cyklofosfamid [Czech]; Cytoxan Lyoph; Endoxan R; Lyophilized Cytoxan; Zyklophosphamid [German]; ASTA B518; Asta B 518; B 518; C 0768; CB 4564; SK 20501; B-518; CB-4564; Ciclofosfamida [INN-Spanish]; Cyclophosphamide (INN); Cyclophosphamide (TN); Cyclophosphamide (anhydrous form); Cyclophosphamide (anhydrous); Cyclophosphamidum [INN-Latin]; Cytoxan (TN); Endoxan (TN); Endoxan-Asta; Neosar (TN); Occupation, cyclophosphamide exposure; Procytox (TN); Revimmune (TN); Bis(2-Chloroethyl)phosphami de cyclic propanolamide; Bis(2-Chloroethyl)phosphamide cyclic propanolamide ester; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; D,L-Cyclophosphamide; Cyclophosphamide, (+-)-Isomer; N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide; (+-)-Cyclophosphamide; (-)-Cyclophosphamide; (RS)-Cyclophosphamide; 1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin; 4-Hydroxy-cyclophosphan-mamophosphatide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticancer Agents
|
||||
| Company |
Baxter International Inc
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C7H15Cl2N2O2P
|
||||
| InChI |
InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)
|
||||
| InChIKey |
CMSMOCZEIVJLDB-UHFFFAOYSA-N
|
||||
| CAS Number |
CAS 6055-19-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
10090, 87150, 141705, 141706, 598053, 5080187, 7979009, 8151862, 10524283, 11110909, 11335421, 11360660, 11363752, 11366314, 11368876, 11371419, 11374027, 11377038, 11406490, 11461632, 11484807, 11488962, 11490186, 11492119, 11494672, 11533313, 14848034, 17404801, 25765844, 29222060, 46505441, 47365072, 47440141, 47515205, 48334372, 48413505, 48415829, 48423195, 49855451, 50000789, 50105634, 50105635, 51092052, 53777344, 53788477, 56310899, 56311422, 56313326, 56313987, 57288588
|
||||
| SuperDrug ATC ID |
L01AA01
|
||||
| SuperDrug CAS ID |
cas=000050180
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | ||
| References | |||||
| Ref 536737 | Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54. | ||||
| Ref 542162 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7154). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.